The stock-based compensation costs that have been charged against income were as follows (in thousands):


	13-Weeks Ended
	April 29, 2023		April 30, 2022
Stock-based compensation expense by type:
Stock options	$	220	$	155
Restricted stock units	1,653		2,125
Employee stock purchases	106		158
Director deferred compensation	26		17
Total stock-based compensation expense	2,005		2,455
Income tax benefit recognized	454		557
Stock-based compensation expense, net of income tax	$	1,551	$	1,898

Expense for restricted stock units is shown net of forfeitures which were immaterial for the 13-weeks ended April 29, 2023 and April 30, 2022.


	13-Weeks Ended
	April 29, 2023	April 30, 2022
Stock options	8,188	7,212
Restricted stock unit awards	78,515	107,848
Performance-based restricted stock unit awards	39,567	49,978
Deferred stock units	450	405

At April 29, 2023, the total compensation cost not yet recognized related to unvested restricted stock unit awards was $11.5 million and the weighted-average period over which such awards are expected to be recognized was 1.5 years. There were no unrecognized compensation costs related to unvested stock options at April 29, 2023.

Details of stock options granted, exercise price per share and the weighted-average grant date fair value were as follows:


	13-Weeks Ended
	April 29, 2023		April 30, 2022
Total stock options granted	8,188		7,212
Exercise price	$	58.38	$	46.22
Fair value of stock options	$	26.87	$	21.46

Under the Hibbett, Inc. Amended and Restated Non-Employee Director Equity Plan, 10,469 shares of our common stock were awarded during the 13-weeks ended April 29, 2023 and 6,388 shares of our common stock were awarded during the 13-weeks ended April 30, 2022.

The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows: